CyberKnife: A new paradigm in radiotherapy

Cyberknife radiotherapy for vestibular schwannoma.

Stereotactic radiosurgery is a well-established treatment modality for vestibular schwannoma. Initial reports using single-stage radiosurgery have demonstrated excellent tumor control rates. Many patients now elect to undergo radiosurgery given the potential for tumor control while avoiding the morbidity associated with microsurgical resection. In attempt to improve hearing preservation rates o...

Dose distributions of high-precision radiotherapy treatment: A comparison between the CyberKnife and TrueBeam systems

Background: Several high-precision stereotactic radiation therapy modalities are currently used in clinical settings. We aimed to evaluate whether the CyberKnife (CK) or TrueBeam (TB) radiation treatment systems were more appropriate for treating targets of various morphologies according to the physical properties of each device.  Materials and Methods: Spheres (diameter = 5–50 mm), as well as ...

A New Paradigm in Biology – The Effect of Localization of a Protein on its Anti-genicity

Thymic Carcinoma Treated by CyberKnife Stereotactic Body Radiotherapy

The standard treatment for advanced thymic carcinoma has not yet been established. Most patients have no symptoms until the advanced stage. Radiation therapy has been used for advanced stage cancer, usually in combination with surgery or chemotherapy; however, the survival rates are 30%-50%. We performed hypofractionated stereotactic radiotherapy with CyberKnife (Accuray, Sunnyvale, CA, USA) fo...

Real-time Cherenkov emission portal imaging during CyberKnife® radiotherapy.

The feasibility of real-time portal imaging during radiation therapy, through the Cherenkov emission (CE) effect is investigated via a medical linear accelerator (CyberKnife(®)) irradiating a partially-filled water tank with a 60 mm circular beam. A graticule of lead/plywood and a number of tissue equivalent materials were alternatively placed at the beam entrance face while the induced CE at t...